Matthew A Inlay

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development
    Matthew A Inlay
    Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California 94305, USA
    Genes Dev 23:2376-81. 2009
  2. ncbi Identification of the earliest natural killer cell-committed progenitor in murine bone marrow
    John W Fathman
    Institute of Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
    Blood 118:5439-47. 2011
  3. ncbi Flk2+ common lymphoid progenitors possess equivalent differentiation potential for the B and T lineages
    Holger Karsunky
    Institute of Stem Cell Biology and Regenerative Medicine, Department of Pathology, Stanford University School of Medicine, CA, USA
    Blood 111:5562-70. 2008
  4. ncbi MiDReG: a method of mining developmentally regulated genes using Boolean implications
    Debashis Sahoo
    Department of Electrical Engineering, Stanford University, Stanford, CA 94305, USA
    Proc Natl Acad Sci U S A 107:5732-7. 2010
  5. ncbi An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells
    Chad Tang
    Institute of Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California, USA
    Nat Biotechnol 29:829-34. 2011
  6. ncbi Early TCR expression and aberrant T cell development in mice with endogenous prerearranged T cell receptor genes
    Thomas Serwold
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
    J Immunol 179:928-38. 2007
  7. ncbi Overexpression of BCL2 enhances survival of human embryonic stem cells during stress and obviates the requirement for serum factors
    Reza Ardehali
    Department of Internal Medicine, Division of Cardiovascular Medicine, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA
    Proc Natl Acad Sci U S A 108:3282-7. 2011

Collaborators

Detail Information

Publications7

  1. ncbi Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development
    Matthew A Inlay
    Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California 94305, USA
    Genes Dev 23:2376-81. 2009
    ....
  2. ncbi Identification of the earliest natural killer cell-committed progenitor in murine bone marrow
    John W Fathman
    Institute of Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
    Blood 118:5439-47. 2011
    ..Taken together, our data provide a high-resolution in vivo analysis of the earliest steps of NK cell commitment and maturation...
  3. ncbi Flk2+ common lymphoid progenitors possess equivalent differentiation potential for the B and T lineages
    Holger Karsunky
    Institute of Stem Cell Biology and Regenerative Medicine, Department of Pathology, Stanford University School of Medicine, CA, USA
    Blood 111:5562-70. 2008
    ..Thus, Flk2 expression defines a homogeneous, readily obtainable subset of bone marrow CLP that is completely lymphoid-committed and can differentiate equivalently well into both B and T lineages...
  4. ncbi MiDReG: a method of mining developmentally regulated genes using Boolean implications
    Debashis Sahoo
    Department of Electrical Engineering, Stanford University, Stanford, CA 94305, USA
    Proc Natl Acad Sci U S A 107:5732-7. 2010
    ..These data demonstrate the power of MiDReG in predicting functionally important intermediate genes in a given developmental pathway that is defined by a mutually exclusive gene expression pattern...
  5. ncbi An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells
    Chad Tang
    Institute of Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California, USA
    Nat Biotechnol 29:829-34. 2011
    ..Immunodepletion with antibodies against SSEA-5 and two additional PSMs completely removed teratoma-formation potential from incompletely differentiated hESC cultures...
  6. ncbi Early TCR expression and aberrant T cell development in mice with endogenous prerearranged T cell receptor genes
    Thomas Serwold
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
    J Immunol 179:928-38. 2007
    ....
  7. ncbi Overexpression of BCL2 enhances survival of human embryonic stem cells during stress and obviates the requirement for serum factors
    Reza Ardehali
    Department of Internal Medicine, Division of Cardiovascular Medicine, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA
    Proc Natl Acad Sci U S A 108:3282-7. 2011
    ....